Category
Primary
pharmaceutical-drugs · embed-ft 0.28
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Also (top-3)
Tech stack
AI readiness
AI training policy
allowed
AI-bot protection
AI files
Evidence
llms.txt
Compliance (GEO / GDPR)
TLD
Overview
Title
PT-141 (Bremelanotide): The Research Record, Set in Order
Description
PT-141 (bremelanotide) is a melanocortin receptor agonist approved in 2019 for HSDD in premenopausal women. A composed digest of the trials, the central mechanism, and the tolerability record.
Final URL
Language
en (html)
Scanned at
2026-06-25 15:27:43